Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIBE: FOLFOXIRI + Bevacizumab vs FOLFIRI + Bevacizumab in mCRC
NCT00719797Phase 3Completed
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Jul 2008
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in metastatic colorectal cancer (mCRC), sponsored by Gruppo Oncologico Nord Ovest. Started Jul 2008; status: completed.
02
Drugs
oxaliplatin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00719797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719797.